{"id":3433,"company":{"country":"GB","currency":"GBP","exchange":"LONDON STOCK EXCHANGE","ipo":"1972-05-22","marketCap":59331.2,"name":"GSK plc","phone":"442080475000","outstanding":4076.15,"symbol":"GSK","website":"https://www.gsk.com/","industry":"Pharmaceuticals"},"price":43.12875,"year":2024,"month":5,"day":3,"weekday":"Friday","title":"The Impact of Currency Fluctuations on GSK Plc Multinational Stock","date":"2024-05-03","url":"/posts/2024/05/03/GSK","content":[{"section":"Introduction","text":"GSK Plc is a multinational pharmaceutical company headquartered in the UK but with operations and revenue generated worldwide. As such, it is exposed to currency fluctuations as it conducts business in various countries with different currencies."},{"section":"Negative Impact of Currency Fluctuations","text":"Currency fluctuations can have a negative impact on GSK's stock value. When the currency of a country where GSK operates weakens against the British pound, the company's revenue earned in that country will be worth less when converted back to pounds. This can lead to a decrease in GSK's overall revenue and subsequently affect its stock price."},{"section":"Case Study 1: Brexit","text":"One real-world case study that demonstrates the impact of currency fluctuations on GSK's stock is Brexit. Following the Brexit referendum in 2016, the British pound significantly depreciated against major currencies. This currency depreciation adversely affected GSK's earnings as its revenue generated from abroad converted into pounds at a less favorable exchange rate. As a result, GSK's stock price experienced a decline."},{"section":"Case Study 2: Emerging Market Currency Crisis","text":"Another case study that highlights currency risk for GSK is the emerging market currency crisis. During such crises, currencies of developing countries experience significant devaluation, which can impact GSK's earnings from those markets. This can lead to a decline in GSK's stock price as investors perceive higher currency risk."},{"section":"Positive Impact of Currency Fluctuations","text":"On the other hand, currency fluctuations can also have a positive impact on GSK's stock value. When the British pound strengthens against other currencies, GSK's revenue generated in those countries will be worth more in pounds. This can increase GSK's overall revenue and potentially boost its stock price."},{"section":"Case Study 3: Weakening of the British Pound","text":"A real-world example of a favorable currency fluctuation for GSK is the weakening of the British pound in the aftermath of the 2008 financial crisis. As the pound depreciated, GSK's revenue earned in countries with stronger currencies translated into more pounds when converted. This positively affected GSK's financial performance and stock price."},{"section":"Balanced Assessment of Currency Risk","text":"Currency fluctuations introduce both risks and opportunities for GSK's multinational stock. On one hand, negative currency fluctuations can lead to decreased revenue and a decline in stock price. On the other hand, positive currency fluctuations can result in increased revenue and a potential boost in stock value. To mitigate currency risk, GSK can implement hedging strategies, such as entering into forward contracts, to manage its exposure to currency fluctuations."},{"section":"Conclusion","text":"Currency fluctuations can significantly impact GSK's multinational stock, presenting both risks and opportunities. Investors and GSK need to closely monitor currency markets and implement appropriate risk management strategies to mitigate potential losses and leverage favorable currency movements."}],"tags":["LongSignals","Long","Pharmaceuticals"],"news":[{"category":"company","date":1714639740,"headline":"UK dividends calendar","id":127384752,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=vrikougiwb"},{"category":"company","date":1714635180,"headline":"GLOBAL BROKER RATINGS: Deutsche Bank cuts Starbucks, CFRA ups Logitech","id":127384753,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=pvo3h4omog"},{"category":"company","date":1714626250,"headline":"GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags","id":127374176,"image":"https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","symbol":"GSK","publisher":"Yahoo","summary":"GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...","url":"https://finance.yahoo.com/news/gsk-first-quarter-2024-earnings-050410236.html"},{"category":"company","date":1714625280,"headline":"LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC","id":127384681,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=n9la54jy92"},{"category":"company","date":1714578137,"headline":"GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook","id":127353888,"image":"https://media.zenfs.com/en/Benzinga/2b0afee3414a602f733da4778160b982","symbol":"GSK","publisher":"Yahoo","summary":"Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun","url":"https://finance.yahoo.com/news/gsk-sees-strong-demand-vaccines-154217851.html"},{"category":"company","date":1714568340,"headline":"GSK Forecasts a Year of Strong Growth","id":127365463,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471607331"},{"category":"company","date":1714566420,"headline":"7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024","id":127360242,"image":"","symbol":"GSK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471550397"},{"category":"company","date":1714565257,"headline":"FTSE 100 Live 1 May: Index flat before US Fed interest rates call, Aston Martin falls, BT among top risers","id":127347428,"image":"https://static.standard.co.uk/2023/12/04/13/03/ftse100live.JPG.jpg?width=1200\u0026auto=webp\u0026quality=75","symbol":"GSK","publisher":"Yahoo","summary":"Upgraded profit guidance by GSK stood out today in a session featuring updates by Next, Smith \u0026 Nephew and Sensodyne business Haleon.  The quartet all signalled robust trading at the start of 2024, helping the FTSE 100 index to begin May in resilient fashion.  Traders are also looking ahead to tonight’s US Federal Reserve decision and whether September is still the most likely month for the first cut.","url":"https://www.standard.co.uk/business/ftse-100-live-01-may-next-aston-martin-dominos-bank-of-england-mortgage-interest-rate-b1154843.html"},{"category":"company","date":1714564560,"headline":"LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision","id":127351883,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=hmhvi0ru1t"},{"category":"company","date":1714563300,"headline":"GSK Pharma put volume heavy and directionally bearish","id":127365467,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471462419"},{"category":"company","date":1714562975,"headline":"GSK raises profit guidance as vaccine demand grows","id":127347430,"image":"https://s.yimg.com/ny/api/res/1.2/1PJOzADW10O0WsCbFOhMgw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://media.zenfs.com/en/snappa.ukfinance/f7bc294a3bde9d786e8a728f618a2d74","symbol":"GSK","publisher":"Yahoo","summary":"Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.","url":"https://uk.finance.yahoo.com/news/gsk-raises-profit-guidance-vaccine-112935816.html"},{"category":"company","date":1714561502,"headline":"GSK (GSK) Q1 Earnings and Revenues Surpass Estimates","id":127347431,"image":"https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926","symbol":"GSK","publisher":"Yahoo","summary":"Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?","url":"https://finance.yahoo.com/news/gsk-gsk-q1-earnings-revenues-110502541.html"},{"category":"company","date":1714561320,"headline":"GSK Updates Share Capital and Voting Rights","id":127365468,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471406341"},{"category":"company","date":1714557480,"headline":"GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q1 2024","id":127365469,"image":"","symbol":"GSK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471295660"},{"category":"company","date":1714555944,"headline":"Trending tickers: Amazon, AMD, GSK and Aston Martin","id":127344902,"image":"https://s.yimg.com/ny/api/res/1.2/F.4Ps4L2Hnz1GcrjB71L1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://s.yimg.com/os/creatr-uploaded-images/2024-02/bc22d340-c9d5-11ee-b7be-d8c629ccfe7c","symbol":"GSK","publisher":"Yahoo","summary":"The latest investor updates on stocks that are trending on Wednesday.","url":"https://uk.finance.yahoo.com/news/amazon-amd-gsk-aston-martin-trending-tickers-093224387.html"},{"category":"company","date":1714555740,"headline":"GSK Reveals Updated Voting Rights Count","id":127365470,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471249122"},{"category":"company","date":1714553642,"headline":"Stocks to Watch Wednesday: Amazon, Starbucks, Pinterest, AMD","id":127347433,"image":"https://s.yimg.com/ny/api/res/1.2/z1aJwwCocHcwCgfFNPl96w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/62d141cb5cc8f55e52d96a5303204d9e","symbol":"GSK","publisher":"Yahoo","summary":"**↗️** **Amazon.com (AMZN)**: The company reported a surge in first-quarter sales as the AI boom powered growth in its cloud-computing unit. Amazon.com stock was higher in premarket trading. **↘️** **Starbucks (SBUX)**: The coffee chain's stock slid more than 12% in premarket.","url":"https://finance.yahoo.com/m/20ba4f19-fa4d-38ac-ab47-31f43d635adb/stocks-to-watch-wednesday%3A.html"},{"category":"company","date":1714550460,"headline":"Novartis Is Tracking Well Above the Industry","id":127356251,"image":"","symbol":"GSK","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3471112693"},{"category":"company","date":1714546500,"headline":"LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage","id":127362580,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=zo6nuyhs9y"},{"category":"company","date":1714545600,"headline":"GSK Lifts Guidance After Turnover Beats Expectations","id":127347434,"image":"https://s.yimg.com/ny/api/res/1.2/0ZqSIUINN51_o9XnybD_LQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/5986ad84f9212dcd00bb9e3abc426da1","symbol":"GSK","publisher":"Yahoo","summary":"GSK lifted its full-year guidance after first-quarter core earnings rose 28%, helped by higher sales of vaccines and specialty medicines .","url":"https://finance.yahoo.com/m/5e5489c1-38eb-3c24-b1c8-db9976c43b0d/gsk-lifts-guidance-after.html"},{"category":"company","date":1714542300,"headline":"Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally","id":127351164,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470942446"},{"category":"company","date":1714541220,"headline":"GSK raises 2024 core EPS growth view to 8%-10% from 6%-9%","id":127365474,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470924078"},{"category":"company","date":1714541040,"headline":"GSK reports Q1 core EPS 43.1p, up 28% at CER","id":127365475,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470921568"},{"category":"company","date":1714539840,"headline":"Glaxo: Q1 Earnings Snapshot","id":127365476,"image":"","symbol":"GSK","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=vidxjr8hpa"},{"category":"company","date":1714538100,"headline":"GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line","id":127352262,"image":"","symbol":"GSK","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470878932"},{"category":"company","date":1714535820,"headline":"LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed","id":127352265,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=4tlwnbm08q"},{"category":"company","date":1714535820,"headline":"TOP NEWS: Haleon backs guidance as profit edges up in first quarter","id":127352264,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=wtj4znayut"},{"category":"company","date":1714535400,"headline":"TOP NEWS: GSK expects momentum to continue after strong first quarter","id":127365481,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=l9sw4g769l"},{"category":"company","date":1714531560,"headline":"LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast","id":127352266,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=xr2xzbroba"},{"category":"company","date":1714531200,"headline":"GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; revised full-year profit forecast upwards","id":127365484,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470788766"},{"category":"company","date":1714529040,"headline":"GlaxoSmithKline Announces Strong Q1 and Positive 2024 Outlook","id":127365485,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470761779"},{"category":"company","date":1714528800,"headline":"GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; updates FY24 outlook","id":127365486,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3470758731"},{"category":"company","date":1714527060,"headline":"GET READY: GSK, Haleon, Next, and Smith \u0026 Nephew at 0700 BST","id":127352268,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=daholq23zo"},{"category":"company","date":1714523340,"headline":"GLOBAL BRIEFING: Downturn in Japanese manufacturing stabilises","id":127351042,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=nl6iwgrwa5"},{"category":"company","date":1714508248,"headline":"Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications","id":127336017,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"GSK","publisher":"Yahoo","summary":"Update: FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications","url":"https://finance.yahoo.com/news/ftc-challenging-apos-junk-apos-201728836.html"},{"category":"company","date":1714482180,"headline":"US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition","id":127330774,"image":"","symbol":"GSK","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=4cnxo6anr7"},{"category":"company","date":1714476240,"headline":"Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents","id":127322107,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469372279"},{"category":"company","date":1714473900,"headline":"GSK Pharma call volume above normal and directionally bullish","id":127330776,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469314450"},{"category":"company","date":1714473840,"headline":"GSK Q1 2024 Earnings Preview","id":127330777,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469309863"},{"category":"company","date":1714470660,"headline":"Notable earnings before Wednesday's open","id":127320292,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469230469"},{"category":"company","date":1714468440,"headline":"FTC expands patent listing challenges for drugs","id":127321823,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469174082"},{"category":"company","date":1714467060,"headline":"Sensodyne maker Haleon to shut UK factory with loss of 435 jobs","id":127322371,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=6eo5tebm4t"},{"category":"company","date":1714440420,"headline":"FTC challenges ‘bogus’ patents on Ozempic, other drugs that ‘block competition’","id":127329115,"image":"","symbol":"GSK","publisher":"MarketWatch","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3469564699"},{"category":"company","date":1714395360,"headline":"Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week","id":127295214,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3466852434"},{"category":"company","date":1714383000,"headline":"UK earnings, trading statements calendar - next 21 days","id":127295501,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=ojah0yp6nj"},{"category":"company","date":1714382940,"headline":"Global company events calendar","id":127295221,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=fj3iquo81v"},{"category":"company","date":1714382940,"headline":"UK earnings, trading statements calendar - next 7 days","id":127295502,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=cdpg64f1bq"},{"category":"company","date":1714380690,"headline":"Immatics N.V.: An Intriguing Developmental Concern","id":127293539,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/167157660/image_167157660.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"Immatics N.V. is expected to release clinical data on all four of its candidates in 2024. Read more to see a full investment analysis of IMTX stock.","url":"https://seekingalpha.com/article/4687191-immatics-nv-intriguing-developmental-concern"},{"category":"company","date":1714368120,"headline":"Forget the Fed. These 3 Stocks Will Soar No Matter What","id":127299141,"image":"","symbol":"GSK","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3467023784"},{"category":"company","date":1714127340,"headline":"June 7th Options Now Available For GSK","id":127251010,"image":"","symbol":"GSK","publisher":"Stock Options Channel","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3463546901"},{"category":"company","date":1714096200,"headline":"COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle","id":127254235,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3463869675"},{"category":"company","date":1714067356,"headline":"These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)","id":127224862,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1482998631/image_1482998631.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"The Annual Meeting of ASCO is a major event for clinicians and researchers in the field of oncology. Explore more details here.","url":"https://seekingalpha.com/article/4686392-these-are-the-biotechs-showing-up-at-the-biggest-cancer-meeting-of-the-year-oral-presentations"},{"category":"company","date":1714059264,"headline":"20 Fastest Growing Health Tech Companies in the World","id":127213687,"image":"https://s.yimg.com/ny/api/res/1.2/hKWg62RQ.kbRntamu6JeBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/8e984c21a437e828274169c9f37cff34","symbol":"GSK","publisher":"Yahoo","summary":"In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]","url":"https://finance.yahoo.com/news/20-fastest-growing-health-tech-153424027.html"},{"category":"company","date":1714053265,"headline":"UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology","id":127212738,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"GSK","publisher":"Yahoo","summary":"GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.  GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed \"more than a decade before\" the outbreak of the COVID-19 pandemic.","url":"https://finance.yahoo.com/news/1-glaxosmithkline-sues-pfizer-biontech-135425835.html"},{"category":"company","date":1714052384,"headline":"GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology","id":127212739,"image":"https://media.zenfs.com/en/reuters-finance.com/a53f6a88f9105aaa6ddc07561422c0a4","symbol":"GSK","publisher":"Yahoo","summary":"(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.  GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed \"more than a decade before\" the outbreak of the COVID-19 pandemic.","url":"https://finance.yahoo.com/news/glaxosmithkline-sues-pfizer-biontech-over-133944094.html"},{"category":"company","date":1714049700,"headline":"What's Going On With Pfizer Stock On Thursday?","id":127218815,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3461646921"},{"category":"company","date":1714039260,"headline":"GSK sues Pfizer, BioNTech over COVID-19 vaccines patents","id":127224711,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3461349749"},{"category":"company","date":1713967291,"headline":"GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release","id":127186717,"image":"https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","symbol":"GSK","publisher":"Yahoo","summary":"Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","url":"https://finance.yahoo.com/news/gsk-gsk-earnings-expected-grow-140131545.html"},{"category":"company","date":1713963750,"headline":"Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage","id":127185874,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1483000268/image_1483000268.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"Madrigal recently received FDA approval for its lead candidate resmetirom, targeting a liver condition called NASH. Check out my analysis of MDGL stock here.","url":"https://seekingalpha.com/article/4685718-madrigal-2-challenges-to-overcome-to-maintain-nash-first-mover-advantage"},{"category":"company","date":1713941880,"headline":"GSK’s Jemperli Awaits FDA Expansion Approval","id":127185936,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3459015766"},{"category":"company","date":1713941820,"headline":"CureVac, GSK terminate Pandemic Preparedness Agreement","id":127185937,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3459014715"},{"category":"company","date":1713940200,"headline":"CureVac, GSK announce start of Phase 1 part of investigational H5N1 trial","id":127185939,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3458985082"},{"category":"company","date":1713940200,"headline":"CureVac announces start of Phase 1/2 study in avian influenza","id":127185938,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3458985078"},{"category":"company","date":1713936300,"headline":"GSK: FDA accepts expanded Jemperli indication application for priority review","id":127185940,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3458918516"},{"category":"company","date":1713932040,"headline":"GSK's Jemperli with chemotherapy accepted for priority review by FDA","id":127185941,"image":"","symbol":"GSK","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=8ccivef96r"},{"category":"company","date":1713924540,"headline":"GSK’s Cancer Drug Nears Broader FDA Approval","id":127185943,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3458769292"},{"category":"company","date":1713875640,"headline":"Sanofi reportedly lining up banks for consumer products spinoff","id":127162701,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3457640363"},{"category":"company","date":1713872237,"headline":"Spero Therapeutics Delivers On Game Plan To Create Shareholder Value","id":127159091,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413265641/image_1413265641.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"Spero has excellent downside protection and additional upside from the payments from the Tebipenem HBr deal with GSK. Learn more on SPRO stock here.","url":"https://seekingalpha.com/article/4685311-spero-therapeutics-delivers-on-game-plan-to-create-shareholder-value"},{"category":"company","date":1713857700,"headline":"Wave Life Sciences announces continued momentum in GSK collaboration","id":127161408,"image":"","symbol":"GSK","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3457251989"},{"category":"company","date":1713784320,"headline":"Sanofi reportedly settles 4K Zantac cases for $100M","id":127145495,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3455709844"},{"category":"company","date":1713524280,"headline":"GSK Executives Reinforce Commitment via Share Purchase","id":127101320,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3452143470"},{"category":"company","date":1713523380,"headline":"Brexit Impact On Drugs - Rising Shortages in UK Highlight Brexit Challenges","id":127101321,"image":"","symbol":"GSK","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3452125405"},{"category":"company","date":1713520140,"headline":"GSK Executives Reinvest Dividends in Shares","id":127101322,"image":"","symbol":"GSK","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3452061267"},{"category":"company","date":1713510228,"headline":"Unveiling Pfizer's Potent Cocktail: Key Drivers Of Free Cash Flow Growth","id":127096947,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1357662733/image_1357662733.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"Pfizer announced positive results from a pivotal clinical trial evaluating Abrysvo's efficacy against respiratory syncytial virus. See why PFE stock is a Buy.","url":"https://seekingalpha.com/article/4684677-pfizer-stock-key-drivers-of-free-cash-flow-growth"},{"category":"company","date":1713499980,"headline":"Hepion ends Phase 2 study for NASH drug due to cash restraints","id":127108932,"image":"","symbol":"GSK","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3452566589"},{"category":"company","date":1713499375,"headline":"GSK Trades At Low Price Multiples, But Its Pipeline Needs To Improve","id":127095489,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/988703938/image_988703938.jpg?io=getty-c-w1536","symbol":"GSK","publisher":"SeekingAlpha","summary":"GSK faces challenges with its weaker pipeline, but its strong revenue growth and product mix offer potential in catching up to competitors. Read more here.","url":"https://seekingalpha.com/article/4684652-gsk-trades-at-low-price-multiples-pipeline-needs-to-improve"}]}